Skip to main content
Equibles
APYX logo

APYX · Apyx Medical Corp · Metrics

Track APYX — free

Use APYX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research APYX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.90 +0.01 (+0.35%) At close · Sep 11
Rebalance outlook locked
Market Cap
$122.16M
Shares
42.12M

APYX metrics

68 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.90
Market cap
$122.16M

Price action

20 metrics
Price change (1W)
-4.9%
Price change (30D)
-4.3%
Price change (3M)
-38.2%
Price change (6M)
-20.1%
Price change (YTD)
-17.1%
Price change (1Y)
+45.0%
Trailing year
Price change (5Y)
-72.9%
52-week high
$4.86
52-week low
$2.00
Change from 52-week high
-40.3%
Change from 52-week low
+45.0%
Annualized volatility
79.1%
Annualized volatility (3M)
63.6%
Beta
1.3
RSI (14D)
31.0
Price vs SMA 50
-20.1%
Price vs SMA 200
-23.6%
Avg volume (3M)
115,624
Relative volume
1.4
Average dollar volume
$425,764

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
42.12M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.1×
reciprocal yield 47.8%
P / book
11.5
reciprocal yield 8.7%
FCF yield
-9.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.9×
reciprocal yield 52.5%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 49.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
63.5%
Operating margin
-6.1%
Trailing 12 months
Net margin
-14.7%
Gross profit (TTM)
$37.09M
Operating profit (TTM)
−$3.54M
Net income (TTM)
−$8.61M
Trailing 12 months
Diluted EPS (TTM)
$-0.82
FCF margin
-18.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.35

Growth

11 metrics
Revenue growth YoY
+22.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$58.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.1%
Year over year · more shares
Revenue CAGR (3Y)
+5.9%
Revenue CAGR (5Y)
+13.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-80.8%
Return on assets
-14.1%
Debt / equity
—
Current ratio
5.7
EBITDA (TTM)
−$2.75M
Free cash flow (TTM)
−$11.05M
Quick ratio
4.5
Interest coverage
-0.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$27.62M
Total assets
$61.07M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$10.13M
Capital expenditures (TTM)
$920,000
R&D (TTM)
$3.30M
SG&A (TTM)
$16.93M
Stock compensation (TTM)
$2.42M
R&D / revenue
5.7%
Stock compensation / revenue
4.1%

Ownership (13F)

3 metrics
13F filers
66
13F filer change QoQ
-1
Institutional ownership
49.9%

Short interest

3 metrics
Short interest
0.5%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
27 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 719135 CUSIP 03837C106 13F (30d) 22 filings 22 filers Visit website